Acute Pneumonia and Intravenous Infusion

Everyone knows that if treatment does not bring the desired results, and even does not hinder the development of purulent complications, it means that such treatment is inadequate and does not correspond to the nature of the disease, isn't it? It is an axiom of clinical medicine. Community-acquired pneumonia (CAP) is one of the 10 leading causes of death worldwide. Contemporary results of the treatment of acute pneumonia (AP) indicate the need for the revaluation of the help principles in this disease. In this regard, the results, which the author of these lines has reached many years ago, should be of interest to professionals in this section of the medicine. In this report, we are talking only about the impact of intravenous infusion on treatment of acute pneumonia. So here will be presented only the results of a large study that relate to the topic.